The patients with higher serum PSA levels had older age, a higher rate of DRE abnormalities, a higher rate of prostate cancer or clinically significant cancer detection, a higher number of biopsy cores positive for cancer, and a greater maximum percentage of cancer infiltration in the biopsy cores that those with lower serum PSA levels. This evidence concerns the gene KLK3 and prostate carcinoma.